TMCnet News
Pharma Logistics Market has Evolved Significantly After the Outbreak of the COVID-19 Pandemic, with Vaccine Distributions Getting Streamlined. The Market is Set to Reach USD 146.71 Billion By 2027 - AriztonCHICAGO, Jan. 11, 2023 /PRNewswire/ -- According to Arizton's latest research report, the pharmaceutical logistics market is expected to grow at a CAGR of 8% during 2021-2027. Increased usage of logistics optimization tools, AI, IoT, and intelligent logistics platforms are likely to contribute to the future growth of the pharmaceutical logistics market. North America region accounts for the highest revenue share of 38.70% in the global pharmaceutical logistics market in 2021 and holds the presence of most pharmaceutical suppliers. The US is the leading country worldwide with the highest share of pharmaceuticals. About five top pharmaceutical companies in 2020 were from the US. In the US, branded drugs accounted for around 83.9% of spending. In 2020, about 8.1% of worldwide drug and medicine shipments originated from North America.  Cold chain logistics companies have made a huge footprint since the onset of COVID-19 pandemic due to the growing demand for temperature-controlled biologics, especially vaccines. Since the beginning of 2020, the adoption of state-of-the-art technologies such as telematics and remote monitoring in cold chain logistics is making transportation in the pharmaceutical industry more efficient with better safety and connectivity. On an average, a drug manufacturer can expect a damage rate of around 30% owing to the logistics constraints associated with a pharmaceutical product. In fact, around 25% of vaccines that reach their destination deteriorate due to incorrect shipping, while around 20% of temperature-sensitive drugs experience broken cold chains. As a result, pharma & biotech companies are utilizing logistics from expert logistic providers who can seamlessly deliver drugs across the supply chain, thereby contributing to the overall growth of the market. Third-party logistics companies are utilizing cloud computing solutions and installing IoT devices in refrigerated trucks and containers to facilitate real-time remote temperature monitoring during the transportation of temperature-sensitive drugs and vaccines. Pharmaceutical Logistics Market Report Scope
Click Here to Download the Free Sample Report Digital transformation is expected to offer an opportunity for pharmaceutical logistics companies to gain a competitive advantage. Digitalization can be extremely beneficial to both small and large firms in the pharmaceutical industry. For example, digitalization to develop counterfeit-proof pharmaceuticals with trackable serial numbers to ensure quality while satisfying forthcoming serialization regulations. Pharmaceutical firms can also embrace digitization to fulfill the predicted rise in demand from global markets. They may use digitalization to comply with regulations, uncover manufacturing efficiencies to reduce costs, and swiftly interact with suppliers and distributors using cloud-based information exchanges. DB Schenker, a subsidiary of DB Group, a leading provider in the logistics sector, uses technologies and methods of digitalization to offer customers an attractive range of products. On the one hand, it is incorporating new transport offers into its product portfolio, such as on-demand mobility, and establishing new platforms for its customer interfaces. On the other hand, it supports internal processes with technologies, such as AI, so the company can continue to offer customers fair prices with efficient processes. According to the company, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential to increase transport density and reliability. In 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group (provides priority logistics and transportation solutions for time and temperature-sensitive life science and healthcare products) to provide industry-leading digital supply chain IT solutions for cell and gene therapies. TrakCel is the first provider of integrated cellular orchestration solutions for tracking cell and gene therapy products. Its goal is to provide cell and gene therapy software solutions. Why Should You Buy this Research Report?
The report considers the present scenario of the pharmaceutical logistics market and its market dynamics for 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market. Click Here to Download the Free Sample Report Key Leading Vendors
Market Segmentation Therapy Area
Origin
Product
Function
Geography
Check Out Some of the Top-Selling Related Research Report Pharmaceutical Packaging Market - The global pharmaceutical packaging market is expected to grow at a CAGR of 4.65% and will cross USD 106.37 billion by 2027 from USD 81 billion in 2021 from 2021-2027. The demand for advanced and innovative solutions, such as self-administered drug delivery devices, is rising in high-income countries, bringing lucrative opportunities for the pharmaceutical packaging market. Biopharmaceutical Excipients Market - The global biopharmaceutical excipients market is expected to reach $3.2 billion by 2027. Excipients are fundamental components of any biopharmaceutical drug product, which act as active ingredients, stability enhancers, emulsifying and suspending agents, binders, preservatives, antioxidants, and lubricants. These differ from prodrugs in manufacturing or are present in a finished pharmaceutical product dosage form. Excipients have targeted roles, ranging from protecting the API to easing the manufacturing process, which, in turn, drives the need and stipulation of excipients for developing effective formulations. Medical Device Packaging Market - The global medical device packaging market is expected to grow at a CAGR of over 5.5% from 2022 to 2027. Medical device packaging involves the sterilization of surgical equipment and medical imaging devices. It is performed to keep medical devices free from any contamination. Medical device packaging provides a protective layer, thereby reducing infections. Healthcare Logistics Market – The global healthcare logistics market is expected to reach USD 226.57 billion by 2026. The main factors contributing to the growth of the global healthcare logistics industry are the increasing demand for pharmaceuticals and medical devices, emerging technologies in the healthcare supply chain, a growing collaboration between logistics and healthcare providers, and other factors such as a rising population and growing chronic disease cases increasing trade, etc. Due to the emerging demand for vaccines, COVID-19 was a catalyst for the global healthcare logistics market. Table of Content 1 RESEARCH METHODOLOGY 2 RESEARCH OBJECTIVES 3 RESEARCH PROCESS 4 SCOPE & COVERAGE 4.1 MARKET DEFINITION 4.1.1 INCLUSIONS 4.1.2 EXCLUSIONS 4.1.3 MARKET ESTIMATION CAVEATS 4.2 BASE YEAR 4.3 SCOPE OF THE STUDY 4.3.1 MARKET SEGMENTATION BY THERAPY AREA 4.3.2 MARKET SEGMENTATION BY ORIGIN 4.3.3 MARKET SEGMENTATION BY PRODUCT 4.3.4 MARKET SEGMENTATION BY FUNCTION 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY 5 REPORT ASSUMPTIONS & CAVEATS 5.1 KEY CAVEATS 5.2 CURRENCY CONVERSION 5.3 MARKET DERIVATION 6 MARKET AT A GLANCE 7 INTRODUCTION 7.1 BACKGROUND 7.2 IMPACT OF COVID-19 ON THE GLOBAL SUPPLY CHAIN 8 PREMIUM INSIGHTS 9 MARKET OPPORTUNITIES & TRENDS 9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS 9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS 9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS 10 MARKET GROWTH ENABLERS 10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES 10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE 10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS 11 MARKET RESTRAINTS 11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS 11.2 IMPACT OF THE COVID-19 PANDEMIC 11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS 12 MARKET LANDSCAPE 12.1 MARKET OVERVIEW 12.2 MARKET SIZE & FORECAST 12.2.1 INSIGHTS BY THERAPY AREA 12.2.2 INSIGHTS BY ORIGIN 12.2.3 INSIGHTS BY PRODUCT 12.2.4 INSIGHTS BY FUNCTION 12.2.5 INSIGHTS BY GEOGRAPHY 12.3 FIVE FORCES ANALYSIS 12.3.1 THREAT OF NEW ENTRANTS 12.3.2 BARGAINING POWER OF SUPPLIERS 12.3.3 BARGAINING POWER OF BUYERS 12.3.4 THREAT OF SUBSTITUTES 12.3.5 COMPETITIVE RIVALRY 13 THERAPY AREA 13.1 MARKET SNAPSHOT & GROWTH ENGINE 13.2 MARKET OVERVIEW 13.3 COMMUNICABLE DISEASES 13.3.1 MARKET OVERVIEW 13.3.2 MARKET SIZE & FORECAST 13.3.3 MARKET BY GEOGRAPHY 13.4 ONCOLOGY 13.4.1 MARKET OVERVIEW 13.4.2 MARKET SIZE & FORECAST 13.4.3 MARKET BY GEOGRAPHY 13.5 DIABETES 13.5.1 MARKET OVERVIEW 13.5.2 MARKET SIZE & FORECAST 13.5.3 MARKET BY GEOGRAPHY 13.6 CARDIOVASCULAR DISEASES 13.6.1 MARKET OVERVIEW 13.6.2 MARKET SIZE & FORECAST 13.6.3 MARKET BY GEOGRAPHY 13.7 AUTOIMMUNE DISEASES 13.7.1 MARKET OVERVIEW 13.7.2 MARKET SIZE & FORECAST 13.7.3 MARKET BY GEOGRAPHY 13.8 NEUROLOGICAL DISORDERS 13.8.1 MARKET OVERVIEW 13.8.2 MARKET SIZE & FORECAST 13.8.3 MARKET BY GEOGRAPHY 13.9 PAIN MANAGEMENT 13.9.1 MARKET OVERVIEW 13.9.2 MARKET SIZE & FORECAST 13.9.3 MARKET BY GEOGRAPHY 13.10 RESPIRATORY DISEASES 13.10.1 MARKET OVERVIEW 13.10.2 MARKET SIZE & FORECAST 13.10.3 MARKET BY GEOGRAPHY 13.11 OTHERS 13.11.1 MARKET OVERVIEW 13.11.2 MARKET SIZE & FORECAST 13.11.3 MARKET BY GEOGRAPHY 14 ORIGIN 14.1 MARKET SNAPSHOT & GROWTH ENGINE 14.2 MARKET OVERVIEW 14.3 BRANDED DRUGS 14.3.1 MARKET OVERVIEW 14.3.2 MARKET SIZE & FORECAST 14.3.3 MARKET BY GEOGRAPHY 14.4 GENERIC DRUGS 14.4.1 MARKET OVERVIEW 14.4.2 MARKET SIZE & FORECAST 14.4.3 MARKET BY GEOGRAPHY 14.5 OTC 14.5.1 MARKET OVERVIEW 14.5.2 MARKET SIZE & FORECAST 14.5.3 MARKET BY GEOGRAPHY 15 PRODUCT 15.1 MARKET SNAPSHOT & GROWTH ENGINE 15.2 MARKET OVERVIEW 15.3 SMALL MOLECULE DRUGS 15.3.1 MARKET OVERVIEW 15.3.2 MARKET SIZE & FORECAST 15.3.3 MARKET BY GEOGRAPHY 15.4 BIOLOGICS 15.4.1 MARKET OVERVIEW 15.4.2 MARKET SIZE & FORECAST 15.4.3 MARKET BY GEOGRAPHY 15.5 MONOCLONAL ANTIBODIES 15.5.1 MARKET OVERVIEW 15.5.2 MARKET SIZE & FORECAST 15.6 VACCINES 15.6.1 MARKET OVERVIEW 15.6.2 MARKET SIZE & FORECAST 15.7 OTHERS 15.7.1 MARKET OVERVIEW 15.7.2 MARKET SIZE & FORECAST 16 FUNCTION 16.1 MARKET SNAPSHOT & GROWTH ENGINE 16.2 MARKET OVERVIEW 16.3 TRANSPORTATION 16.3.1 MARKET OVERVIEW 16.3.2 MARKET SIZE & FORECAST 16.3.3 MARKET BY GEOGRAPHY 16.4 ROAD 16.4.1 MARKET OVERVIEW 16.4.2 MARKET SIZE & FORECAST 16.5 WATER 16.5.1 MARKET OVERVIEW 16.5.2 MARKET SIZE & FORECAST 16.6 AIR 16.6.1 MARKET OVERVIEW 16.6.2 MARKET SIZE & FORECAST 16.7 WAREHOUSING 16.7.1 MARKET OVERVIEW 16.7.2 MARKET SIZE & FORECAST 16.7.3 MARKET BY GEOGRAPHY 16.8 OTHERS 16.8.1 MARKET OVERVIEW 16.8.2 MARKET SIZE & FORECAST 16.8.3 MARKET BY GEOGRAPHY 17 GEOGRAPHY 17.1 MARKET SNAPSHOT & GROWTH ENGINE 17.2 GEOGRAPHIC OVERVIEW 18 NORTH AMERICA 18.1 MARKET OVERVIEW 18.2 MARKET SIZE & FORECAST 18.3 NORTH AMERICA BY THERAPY AREA 18.4 NORTH AMERICA BY ORIGIN 18.5 NORTH AMERICA BY PRODUCT 18.6 NORTH AMERICA BY FUNCTION 18.7 KEY COUNTRIES 18.7.1 US: MARKET SIZE & FORECAST 18.7.2 CANADA: MARKET SIZE & FORECAST 19 EUROPE 19.1 MARKET OVERVIEW 19.2 MARKET SIZE & FORECAST 19.3 EUROPE BY THERAPY AREA 19.4 EUROPE BY ORIGIN 19.5 EUROPE BY PRODUCT 19.6 EUROPE BY FUNCTION 19.7 KEY COUNTRIES 19.7.1 GERMANY: MARKET SIZE & FORECAST 19.7.2 FRANCE: MARKET SIZE & FORECAST 19.7.3 UK: MARKET SIZE & FORECAST 19.7.4 ITALY: MARKET SIZE & FORECAST 19.7.5 SPAIN: MARKET SIZE & FORECAST 20 APAC 20.1 MARKET OVERVIEW 20.2 MARKET SIZE & FORECAST 20.3 APAC BY THERAPY AREA 20.4 APAC BY ORIGIN 20.5 APAC BY PRODUCT 20.6 APAC BY FUNCTION 20.7 KEY COUNTRIES 20.7.1 CHINA: MARKET SIZE & FORECAST 20.7.2 JAPAN: MARKET SIZE & FORECAST 20.7.3 INDIA: MARKET SIZE & FORECAST 20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST 20.7.5 AUSTRALIA: MARKET SIZE & FORECAST 21 LATIN AMERICA 21.1 MARKET OVERVIEW 21.2 MARKET SIZE & FORECAST 21.3 LATIN AMERICA BY THERAPY AREA 21.4 LATIN AMERICA BY ORIGIN 21.5 LATIN AMERICA BY PRODUCT 21.6 LATIN AMERICA BY FUNCTION 21.7 KEY COUNTRIES 21.7.1 BRAZIL: MARKET SIZE & FORECAST 21.7.2 MEXICO: MARKET SIZE & FORECAST 21.7.3 ARGENTINA: MARKET SIZE & FORECAST 22 MIDDLE EAST & AFRICA 22.1 MARKET OVERVIEW 22.2 MARKET SIZE & FORECAST 22.3 MIDDLE EAST & AFRICA BY THERAPY AREA 22.4 MIDDLE EAST & AFRICA BY ORIGIN 22.5 MIDDLE EAST & AFRICA BY PRODUCT 22.6 MIDDLE EAST & AFRICA BY FUNCTION 22.7 KEY COUNTRIES 22.7.1 TURKEY: MARKET SIZE & FORECAST 22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST 22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST 23 COMPETITIVE LANDSCAPE 23.1 COMPETITION OVERVIEW 23.1.1 AMERISOURCEBERGEN 23.1.2 DB GROUP 23.1.3 DEUTSCHE POST DHL 23.1.4 CEVA LOGISTICS 23.1.5 UNITED PARCEL SERVICE 23.1.6 FEDEX 23.1.7 KUEHNE+NAGEL
24 KEY COMPANY PROFILES 24.1 AMERISOURCEBERGEN 24.1.1 BUSINESS OVERVIEW 24.1.2 SERVICE OFFERINGS 24.1.3 KEY STRATEGIES 24.1.4 KEY STRENGTHS 24.1.5 KEY OPPORTUNITIES 24.2 CEVA LOGISTICS 24.3 DB GROUP 24.4 DEUTSCHE POST DHL 24.5 FEDEX 24.6 KUEHNE + NAGEL 24.7 UNITED PARCEL SERVICE 25 OTHER PROMINENT VENDORS 25.1 ABS LOGISTICS 25.1.1 BUSINESS OVERVIEW 25.1.2 SERVICE OFFERINGS 25.2 AWL INDIA 25.3 ALLOGA 25.4 BOLLORÉ LOGISTICS 25.5 CARDINAL HEALTH 25.6 C.H. ROBINSON 25.7 COLD CHAIN TECHNOLOGIES 25.8 CRYOPDP 25.9 DPD 25.10 DSV 25.11 FARMASOFT 25.12 JEENA & COMPANY 25.13 LUFTHANSA CARGO 25.14 A.P. MOLLER - MAERSK 25.15 MEDLINE 25.16 NIPPON EXPRESS 25.17 NOATUM LOGISTICS 25.18 OWENS & MINOR 25.19 OXIMIO 25.20 PHARMA LOGISTICS 25.21 PHOENIX GROUP 25.22 PAREXEL INTERNATIONAL 25.23 SEKO LOGISTICS 25.24 SINGAPORE POST 25.25 SINOTRANS 25.26 XPO LOGISTICS 25.27 YOURWAY 25.28 YUSEN LOGISTICS 26 REPORT SUMMARY 26.1 KEY TAKEAWAYS 26.2 STRATEGIC RECOMMENDATIONS 27 QUANTITATIVE SUMMARY 27.1 MARKET BY GEOGRAPHY 27.2 MARKET BY THERAPY AREA 27.3 MARKET BY ORIGIN 27.4 MARKET BY PRODUCT 27.5 MARKET BY FUNCTION 27.6 NORTH AMERICA BY THERAPY AREA 27.7 NORTH AMERICA BY ORIGIN 27.8 NORTH AMERICA BY PRODUCT 27.9 NORTH AMERICA BY FUNCTION 27.10 EUROPE BY THERAPY AREA 27.11 EUROPE BY ORIGIN 27.12 EUROPE BY PRODUCT 27.13 EUROPE BY FUNCTION 27.14 APAC BY THERAPY AREA 27.15 APAC BY ORIGIN 27.16 APAC BY PRODUCT 27.17 APAC BY FUNCTION 27.18 LATIN AMERICA BY THERAPY AREA 27.19 LATIN AMERICA BY ORIGIN 27.20 LATIN AMERICA BY PRODUCT 27.21 LATIN AMERICA BY FUNCTION 27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA 27.23 MIDDLE EAST & AFRICA BY ORIGIN 27.24 MIDDLE EAST & AFRICA BY PRODUCT 27.25 MIDDLE EAST & AFRICA BY FUNCTION 28 APPENDIX 28.1 ABBREVIATIONS About Us: Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services. We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.? Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.? Call: +1-312-235-2040? ????????? +1 302 469 0707? Mail: [email protected]  Photo: https://mma.prnewswire.com/media/1981618/Pharmaceutical_Logistics_Market.jpg 
|
View original content: